The Relationship between Neovascular Age-Related Macular Degeneration and Erectile Dysfunction

The Relationship between Neovascular Age-Related Macular Degeneration and Erectile Dysfunction

Purpose. To evaluate association between erectile dysfunction (ED) and neovascular age-related macular degeneration (AMD). Methods. 195 men enrolled in this cross-sectional study. 90 of them had neovascular AMD and 105 of them were healthy volunteers. The International Index of Erectile Function (I...

Full description

Saved in:

Bibliographic Details
Main Authors:	Harun Çakmak, Tolga Kocatürk, Sema Oruç Dündar, Mehmet Dündar, Müjdat Karabulut
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2013/589274
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Photodynamic therapy for neovascular age-related macular degeneration
by: Richard P.L. Wormald, MA, MB, BCh, MSc, FRCS, FRCOphth, et al.
Published: (2005-06-01)

Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
by: Laurenz Pauleikhoff, et al.
Published: (2025-03-01)

Research progress in molecular omics of neovascular age-related macular degeneration
by: ZHUANG Xuenan, et al.
Published: (2025-02-01)

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)

Evaluation of the efficacy of surgical treatment of cataracts in patients with neovascular age-related macular degeneration
by: A. Zh. Fursova, et al.
Published: (2024-12-01)

Risk Factor of Neovascular Agerelated Macular Degeneration Progression after Cataract Surgery
by: V. G. Likhvantseva, et al.
Published: (2024-04-01)

Short-term natural history of macular neovascularization in nonexudative age-related macular degeneration using multimodal imaging
by: Anna-Maria Haas, et al.
Published: (2025-07-01)

Long-term outcomes of drusenoid retinal pigment epithelium detachment in eyes with age-related macular degeneration
by: Sinem Karabulut, et al.
Published: (2025-06-01)

Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography
by: Yan-Mei Shi, et al.
Published: (2025-08-01)

Real-world outcomes and treatment patterns in Colombian patients with neovascular age-related macular degeneration and diabetic macular edema
by: Joshua Kock, et al.
Published: (2025-06-01)

Obesity as a Risk Factor for the Ineffectiveness of Antiangiogenic Treatment of Neovascular Age-related Macular Degeneration
by: V. G. Likhvantseva, et al.
Published: (2024-04-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Fixed Regimen Treatment in Unselected Naïve Patients Cohort with Neovascular Age-Related Macular Degeneration
by: Ricardo P. Casaroli-Marano, et al.
Published: (2020-01-01)

Management of Neovascular Age-Related Macular Degeneration in Clinical Practice: Initiation, Maintenance, and Discontinuation of Therapy
by: Pearse A. Keane, et al.
Published: (2011-01-01)

Efficacy of aflibercept in patients with neovascular age-related macular degeneration when combined with cataract surgery
by: A. A. Kuznetsov, et al.
Published: (2018-10-01)

Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
by: V. G. Likhvantseva, et al.
Published: (2022-10-01)

Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
by: Marco Lupidi, et al.
Published: (2025-07-01)

Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
by: Setsuko Kawakami, et al.
Published: (2021-01-01)

Systemic oxidative stress levels and their associations with the risk of neovascular age-related macular degeneration and treatment response
by: Maiko Abe, et al.
Published: (2025-02-01)

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Automated fluid monitoring to optimize the follow-up of neovascular age-related macular degeneration patients in the Brazilian population
by: Virginia Mares, et al.
Published: (2025-07-01)

The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study
by: V. V. Neroev, et al.
Published: (2023-12-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Preferences of Hospital Pharmacists for the Different Attributes of Intravitreal Treatments for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Spain: The SEEKING Study
by: José Luis Poveda, et al.
Published: (2025-05-01)

Is Spectral-Domain Optical Coherence Tomography Essential for Flexible Treatment Regimens with Ranibizumab for Neovascular Age-Related Macular Degeneration?
by: Abdullah Ozkaya, et al.
Published: (2013-01-01)

Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01)

Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1
by: Jeffrey S. Heier, MD, et al.
Published: (2025-09-01)

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration
by: Masaaki Saito, et al.
Published: (2025-08-01)

Safety and effectiveness of brolucizumab in patients with neovascular age-related macular degeneration: A phase IV study from India
by: Asim K Ghosh, et al.
Published: (2025-06-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Zhou J, et al.
Published: (2025-06-01)

Evidence for Whom? A Systematic Review of Eligibility Criteria in RCTs of Anti-VEGF for Neovascular Age-Related Macular Degeneration
by: Andreas Arnold-Vangsted, et al.
Published: (2025-07-01)

Study of the Level of Pro- and Antiangiogenic Growth Factors in Vitreous Fluid in Neovascular Age-Related Macular Degeneration on the Background of Treatment
by: M. M. Arkhipova, et al.
Published: (2022-07-01)

Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom
by: Muiz Musadiq, et al.
Published: (2025-06-01)

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients
by: Stefano Lazzeri, et al.
Published: (2012-01-01)